Hologic taps J&J vet McMahon as new CFO | Personnel Moves

May 14, 2014 By Brad Perriello

Hologic (NSDQ:HOLX) said it tapped the former finance vice president at a Johnson & Johnson (NYSE:JNJ) spinout to be its new CFO.

Robert McMahon was worldwide vice president of finance & business development at J&J’s Ortho-Clinical Diagnostics business, according to a press release. McMahon is slated to take the finance reins at Hologic May 26, according to the release.

In late March J&J accepted a $4 billion offer from private equity giant Carlyle Group to acquire the Ortho-Clinical Diagnostics blood testing business. Carlyle beat out several other PE shops with a $4.15 billion bid in January.

McMahon is replacing Glenn Muir, who is slated to retire but will remain available to help with the transition through November, Hologic said. Yesterday Hologic president & CEO Stephen MacMillan, himself a relatively new appointment at the women’s health company, cited McMahon’s 20 years of financial leadership experience in the medical device industry.

“Bob has an established track record leading global finance organizations and he will significantly strengthen our executive team," MacMillan said in prepared remarks. "Bob’s strong operational experience will play an important role as we are repositioning our organization to focus on organic growth via stronger executional discipline. We are building a winning team and Bob brings core skills and leadership capabilities that will help improve our performance."

Hologic also said it named Peter Valenti III as president of its breast health division, also effective May 26. Valenti is a 30-year medical device veteran whose résumé includes stints at Bausch & Lomb, Covidien (NYSE:COV), J&J and the New England Consulting Group, according to the release.

"Peter is a welcomed addition to the team as part of the new leadership structure," MacMillan said. "Our enhanced senior leadership team is squarely focused on accelerating organic growth, improving our operating and financial performance, and continuing to deliver the best solutions for our customers. Peter’s track record of accelerating growth in businesses combined with his strong marketing background will be an important addition to our organization."

Mass. Life Sciences Center CEO Bannister to step down
Susan Windham-Bannister plans to step down from the Mass. Life Sciences Center after a 6-year run at the quasi-public agency charged with fostering research and economic development in the Commonwealth’s substantial life science sector.
Read more

Wright Medical CEO Palmisano is on board with Avedro
Ophthalmic medical device maker Avedro named Wright Medical (NSDQ:WMGI) president & CEO Robert Palmisano to its board of directors.
Read more

Histogenics has a new CEO
Histogenics Corp. named Adam Gridley as its president & CEO, less than a year after the regenerative medicine company replaced Patrick O’Donnell with AstraZeneca veteran Peter Greenleaf.
Read more

NeuWave Medical nabs former SuperDimension CEO Sullivan
NeuWave Medical said it named former SuperDimension president & CEO Daniel Sullivan to take over the corner office. Covidien acquired SuperDimension in March 2012 for $300 million plus milestones.
Read more

Ga. warehouse workers sue Sterigenics, ConMed over EtO exposure
Fifty-three people who worked in an Atlanta-area warehouse that stored medical devices sterilized by ethylene oxide (EtO) filed suit this week against Sterigenics and its parent company over exposure to the gas. The plaintiffs or their families claim that long-term EtO exposure to the sterilized devices, which they unloaded, handled, warehoused and distributed, caused multiple… […]
FDA eases regs on certain device changes during pandemic
The FDA will allow limited changes to certain devices so medtech companies can address manufacturing and supply chain issues due to COVID-19-related disruptions. In a guidance released yesterday, the agency said it would allow changes to devices approved through its premarket approval (PMA) and humanitarian device exemption (HDE) pathways as long as those changes do… […]
15 heart devices that could boost their manufacturers’ sales
Before the coronavirus pandemic hit, medtech companies large and small were making notable news with a number of innovative heart devices. Some of these same companies took a big hit to their bottom lines when the danger of spreading COVID-19 and using up precious personal protective equipment convinced hospitals to limit non-urgent procedures. Now hospitals… […]
This wearable could help people practice safe distancing amid COVID-19
Imec spinoff Lopos, with the Ghent University (Belgium) announced the Lopos SafeDistance wearable for promoting safety during the COVID-19 pandemic. As businesses attempt to return to in-person activities, the collaboration designed the wearable device to warn employees through an audible or haptic alarm when they are violating social distancing guidelines as they approach each other.… […]
FDA launches COVID-19 research initiative
The FDA has entered an agreement with healthcare analytics company Aetion to research urgent questions about COVID-19. The New York City-based company said the research will support FDA objectives to explore the natural history of the disease, as well as treatment and diagnostic patterns using relevant, novel data sources and analyzing these data according to well-established principles.… […]
Medtronic execs see quick recovery, increased M&A
If Medtronic’s troubling Q4 report offers a snapshot of a company hit hard by COVID-19, the next image in the sequence may show a faster-than-expected recovery and increased merger-and-acquisition of smaller companies. In the quarterly call on Thursday morning, Medtronic CEO Geoff Martha and CFO Karen Parkhill expressed optimism that the company’s businesses already are showing signs… […]
Webinar: How COVID-19 is changing medical device regulation, clinical trials and reimbursement
Tuesday, June 23, 2020 11:30 a.m. eastern time / 8:30 a.m. pacific time As the life sciences industry works to contain the COVID-19 outbreak, it is clear that the dynamics of the medical device and digital health industries are being disrupted. Going virtual is the new normal and executives of medtech and healthtech… […]
IMDRF recommends UL 2900 compliance for medical device cybersecurity
By Stewart Eisenhart, Emergo Group Recent guidance published by the International Medical Devices Regulators Forum (IMDRF) that covers medical device cybersecurity best practices includes recommendations that manufacturers comply with the UL 2900 set of standards for network-connectable devices. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post… […]
Goddard teams with Swab56 on COVID-19 test swabs
Mechanical engineering and industrial design company Goddard announced that it is working with the Swab56 Project to rapidly increase the production of Swab56’s test swabs, which are used in healthcare facilities to test for COVID-19. As news reports have documented, traditional nasopharyngeal swabs are in short supply as healthcare facilities around the world struggle to keep… […]
This patient-mover got an emergency COVID-19 nod from the FDA
AR Tech, a division of A&R Tarpaulins, announced today that the FDA has granted an EUA for its Patient Isolation Transportation Unit (PITU) to help hospitals better manage the COVID-19 pandemic. “PITU is a game-changer in this fight against the pandemic because it is a negative pressure isolation enclosure that makes working with highly contagious diseases… […]
Sommetrics lands ISO 13485 certification
Sleep apnea treatment device startup Sommetrics announced yesterday that its quality management system has been certified to the ISO 13485:2016 standard. During the audit process required for certification, Sommetrics was also evaluated and found to be in compliance with the standards of the Medical Device Single Audit Program (MDSAP) for Canada. “This is an important… […]